These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 25104798)

  • 21. Monocyte fate in atherosclerosis.
    Hilgendorf I; Swirski FK; Robbins CS
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):272-9. PubMed ID: 25538208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of mast cells in the pathogenesis of atherosclerosis].
    Czyzewska-Buczyńska A; Witkiewicz W
    Przegl Lek; 2011; 68(3):171-4. PubMed ID: 21812235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the immune response in atherosclerosis: It's time for clinical trials!
    Joffre J; Ait-Oufella H
    Arch Cardiovasc Dis; 2017 Dec; 110(12):643-645. PubMed ID: 29051009
    [No Abstract]   [Full Text] [Related]  

  • 24. The Effect of Statins through Mast Cells in the Pathophysiology of Atherosclerosis: a Review.
    Kouhpeikar H; Delbari Z; Sathyapalan T; Simental-Mendía LE; Jamialahmadi T; Sahebkar A
    Curr Atheroscler Rep; 2020 May; 22(5):19. PubMed ID: 32458165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlamydia pneumoniae and atherosclerosis: the role of mast cells.
    Di Pietro M; Schiavoni G; Del Piano M; Shaik Y; Boscolo P; Caraffa A; Grano M; Teté S; Conti F; Sessa R
    J Biol Regul Homeost Agents; 2009; 23(2):65-9. PubMed ID: 19589286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased Number of Mast Cells in Atherosclerotic Lesions Correlates with the Presence of Myeloid but not Plasmacytoid Dendritic Cells as well as Pro-inflammatory T Cells.
    Rohm I; Sattler S; Atiskova Y; Kretzschmar D; Pistulli R; Franz M; Jung C; Mall G; Kronert T; Schulze PC; Yilmaz A
    Clin Lab; 2016 Dec; 62(12):2293-2303. PubMed ID: 28164558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel anti-inflammatory therapies for the treatment of atherosclerosis.
    Khan R; Spagnoli V; Tardif JC; L'Allier PL
    Atherosclerosis; 2015 Jun; 240(2):497-509. PubMed ID: 25917947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation and atherosclerosis--revisited.
    Pant S; Deshmukh A; Gurumurthy GS; Pothineni NV; Watts TE; Romeo F; Mehta JL
    J Cardiovasc Pharmacol Ther; 2014 Mar; 19(2):170-8. PubMed ID: 24177335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pLysRS-Ap
    Govindaraj S; Paruchuru LB; Razin E
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular and Molecular Mechanisms of Mast Cells in Atherosclerotic Plaque Progression and Destabilization.
    Elieh-Ali-Komi D; Bot I; Rodríguez-González M; Maurer M
    Clin Rev Allergy Immunol; 2024 Feb; 66(1):30-49. PubMed ID: 38289515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pleiotropic role of interleukin-17 in atherosclerosis.
    Allam G; Abdel-Moneim A; Gaber AM
    Biomed Pharmacother; 2018 Oct; 106():1412-1418. PubMed ID: 30119214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherosclerosis and autoimmunity: a growing relationship.
    Sanjadi M; Rezvanie Sichanie Z; Totonchi H; Karami J; Rezaei R; Aslani S
    Int J Rheum Dis; 2018 May; 21(5):908-921. PubMed ID: 29671956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional diversity of macrophages in vascular biology and disease.
    Park I; Kassiteridi C; Monaco C
    Vascul Pharmacol; 2017 Dec; 99():13-22. PubMed ID: 29074468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune and inflammatory mechanisms of atherosclerosis (*).
    Galkina E; Ley K
    Annu Rev Immunol; 2009; 27():165-97. PubMed ID: 19302038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-33 mediated amplification of allergic response in human mast cells.
    Parveen S; Saravanan DB; Saluja R; Elden BT
    J Recept Signal Transduct Res; 2019 Aug; 39(4):359-367. PubMed ID: 31755331
    [No Abstract]   [Full Text] [Related]  

  • 36. Trained Immunity in Atherosclerotic Cardiovascular Disease.
    Flores-Gomez D; Bekkering S; Netea MG; Riksen NP
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):62-69. PubMed ID: 33147995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunity and Inflammation in Atherosclerosis.
    Wolf D; Ley K
    Circ Res; 2019 Jan; 124(2):315-327. PubMed ID: 30653442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mediators of anaphylaxis.
    Ogawa Y; Grant JA
    Immunol Allergy Clin North Am; 2007 May; 27(2):249-60, vii. PubMed ID: 17493501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atherosclerosis revisited from a clinical perspective: still an inflammatory disease?
    Santovito D; Weber C
    Thromb Haemost; 2017 Jan; 117(2):231-237. PubMed ID: 27975102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mast cells and inflammation.
    Theoharides TC; Alysandratos KD; Angelidou A; Delivanis DA; Sismanopoulos N; Zhang B; Asadi S; Vasiadi M; Weng Z; Miniati A; Kalogeromitros D
    Biochim Biophys Acta; 2012 Jan; 1822(1):21-33. PubMed ID: 21185371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.